Structure–function of human 3α-hydroxysteroid dehydrogenases: genes and proteins

[1]  D. Peehl,et al.  Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells. , 2003, Endocrinology.

[2]  Hsueh-Kung Lin,et al.  Role of human type 3 3alpha-hydroxysteroid dehydrogenase (AKR1C2) in androgen metabolism of prostate cancer cells. , 2003, Chemico-biological interactions.

[3]  D. Tindall,et al.  The role of androgens and the androgen receptor in prostate cancer. , 2002, Cancer letters.

[4]  V. Rice.  Conventional Medical Therapies for Endometriosis , 2002, Annals of the New York Academy of Sciences.

[5]  Pierre Legrand,et al.  Structure of the Human 3α-Hydroxysteroid Dehydrogenase Type 3 in Complex with Testosterone and NADP at 1.25-Å Resolution* , 2001, The Journal of Biological Chemistry.

[6]  N. Palackal,et al.  Crystal structure of human type III 3alpha-hydroxysteroid dehydrogenase/bile acid binding protein complexed with NADP(+) and ursodeoxycholate. , 2001, Biochemistry.

[7]  K. Byth,et al.  Relative expression of progesterone receptors A and B in endometrioid cancers of the endometrium. , 2001, Cancer research.

[8]  F. Labrie,et al.  Human Types 1 and 3 3α-Hydroxysteroid Dehydrogenases: Differential Lability and Tissue Distribution1 , 2001 .

[9]  Michael E. Burczynski,et al.  Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1–AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones , 2000 .

[10]  D. Edwards,et al.  Progesterone receptor isoform A but not B is expressed in endometriosis. , 2000, The Journal of clinical endocrinology and metabolism.

[11]  S. Mellon,et al.  Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Hsueh-Kung Lin,et al.  Genomic structure of rat 3α-hydroxysteroid/dihydrodiol dehydrogenase (3α-HSD/DD, AKR1C9) , 1999, The Journal of Steroid Biochemistry and Molecular Biology.

[13]  T. Penning,et al.  Members of the nuclear factor 1 transcription factor family regulate rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (3alpha-HSD/DD AKR1C9) gene expression: a member of the aldo-keto reductase superfamily. , 1999, Molecular endocrinology.

[14]  Haiching Ma,et al.  Conversion of mammalian 3alpha-hydroxysteroid dehydrogenase to 20alpha-hydroxysteroid dehydrogenase using loop chimeras: changing specificity from androgens to progestins. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  T. Penning,et al.  The arginine 276 anchor for NADP(H) dictates fluorescence kinetic transients in 3 alpha-hydroxysteroid dehydrogenase, a representative aldo-keto reductase. , 1999, Biochemistry.

[16]  T. Penning,et al.  Isoform-specific induction of a human aldo-keto reductase by polycyclic aromatic hydrocarbons (PAHs), electrophiles, and oxidative stress: implications for the alternative pathway of PAH activation catalyzed by human dihydrodiol dehydrogenase. , 1999, Cancer research.

[17]  P. Soucy,et al.  Characteristics of a Highly Labile Human Type 5 17β-Hydroxysteroid Dehydrogenase1. , 1999, Endocrinology.

[18]  J. Jez,et al.  Engineering Steroid 5β-Reductase Activity into Rat Liver 3α-Hydroxysteroid Dehydrogenase† , 1998 .

[19]  T. Penning,et al.  Expression and characterization of four recombinant human dihydrodiol dehydrogenase isoforms: oxidation of trans-7, 8-dihydroxy-7,8-dihydrobenzo[a]pyrene to the activated o-quinone metabolite benzo[a]pyrene-7,8-dione. , 1998, Biochemistry.

[20]  T. Penning,et al.  Dexamethasone regulation of the rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase gene. , 1998, Molecular pharmacology.

[21]  J. Jez,et al.  Mutagenesis of 3 alpha-hydroxysteroid dehydrogenase reveals a "push-pull" mechanism for proton transfer in aldo-keto reductases. , 1998, Biochemistry.

[22]  D. Peehl,et al.  Expression and Characterization of Recombinant Type 2 3α-Hydroxysteroid Dehydrogenase (HSD) from Human Prostate: Demonstration of Bifunctional 3α/17β-HSD Activity and Cellular Distribution , 1997 .

[23]  T. Flynn,et al.  A new nomenclature for the aldo-keto reductase superfamily. , 1997, Biochemical pharmacology.

[24]  M. J. Bennett,et al.  Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. , 1997, Structure.

[25]  F. Labrie,et al.  Molecular Cloning of Human Type 3 3α-Hydroxysteroid Dehydrogenase That Differs from 20α-Hydroxysteroid Dehydrogenase by Seven Amino Acids , 1996 .

[26]  M. J. Bennett,et al.  Structure of 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase complexed with NADP+. , 1996, Biochemistry.

[27]  K. Sato,et al.  Relationship of human liver dihydrodiol dehydrogenases to hepatic bile-acid-binding protein and an oxidoreductase of human colon cells. , 1996, The Biochemical journal.

[28]  C. Lai,et al.  Human aldose reductase: rate constants for a mechanism including interconversion of ternary complexes by recombinant wild-type enzyme. , 1995, Biochemistry.

[29]  T. Penning,et al.  Cloning, sequencing, and functional analysis of the 5'-flanking region of the rat 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase gene. , 1995, Cancer research.

[30]  J. A. Peters,et al.  Neurosteroids and GABAA receptor function. , 1995, Trends in pharmacological sciences.

[31]  K. Cheng,et al.  Substrate Specificity, Gene Structure, and Tissue-specific Distribution of Multiple Human 3α-Hydroxysteroid Dehydrogenases (*) , 1995, The Journal of Biological Chemistry.

[32]  R. Sparkes,et al.  Localization of multiple human dihydrodiol dehydrogenase (DDH1 and DDH2) and chlordecone reductase (CHDR) genes in chromosome 10 by the polymerase chain reaction and fluorescence in situ hybridization. , 1995, Genomics.

[33]  J. Pawlowski,et al.  Overexpression and mutagenesis of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. Role of cysteines and tyrosines in catalysis. , 1994, The Journal of biological chemistry.

[34]  M. Nakanishi,et al.  Molecular cloning of two human liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase isoenzymes that are identical with chlordecone reductase and bile-acid binder. , 1994, The Biochemical journal.

[35]  M. Lewis,et al.  Three-dimensional structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of the aldo-keto reductase superfamily. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Takikawa,et al.  cDNA cloning and expression of the human hepatic bile acid-binding protein. A member of the monomeric reductase gene family. , 1993, The Journal of biological chemistry.

[37]  M. Majewska,et al.  Neurosteroids: Endogenous bimodal modulators of the GABAA receptor mechanism of action and physiological significance , 1992, Progress in Neurobiology.

[38]  T. Nakayama,et al.  Structural and functional comparison of two human liver dihydrodiol dehydrogenases associated with 3 alpha-hydroxysteroid dehydrogenase activity. , 1992, The Biochemical journal.

[39]  T. Penning,et al.  The kinetic mechanism catalysed by homogeneous rat liver 3 alpha-hydroxysteroid dehydrogenase. Evidence for binary and ternary dead-end complexes containing non-steroidal anti-inflammatory drugs. , 1991, The Biochemical journal.

[40]  J. Pawlowski,et al.  Cloning and sequencing of the cDNA for rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase. , 1991, The Journal of biological chemistry.

[41]  T. Nakayama,et al.  Purification and properties of multiple forms of dihydrodiol dehydrogenase from human liver. , 1990, Journal of biochemistry.

[42]  S. Paul,et al.  Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. , 1986, Science.

[43]  T. Penning,et al.  Purification and properties of a 3α-hydroxysteroid dehydrogenase of rat liver cytosol and its inhibition by anti-inflammatory drugs , 1984 .

[44]  S. Liao,et al.  Steroid structure and androgenic activity. Specificities involved in the receptor binding and nuclear retention of various androgens. , 1973, The Journal of biological chemistry.

[45]  J. A. Peters,et al.  Steroid modulation of the GABAA receptor complex: electrophysiological studies. , 1990, Ciba Foundation symposium.

[46]  D. Chadwick,et al.  Steroids and neuronal activity , 1990 .